Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy
Clinical trial NCT05506254 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05506254
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-15
- Primary completion
- 2037-01-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.